SEC Form 4 · accession 0001213900-17-006118
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Harrell
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | D | 500,000 | $0.78 | D | 2,090,750 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017.